270
Participants
Start Date
January 31, 2012
Primary Completion Date
March 31, 2014
Study Completion Date
May 31, 2014
V-Go™
Use of Insulin Delivery Device, V-Go, and the effect on A1C for T2DM patients in five categories of baseline oral antidiabetes drug (OAD) use with or without insulin.
University Physicians Group, Staten Island
North Shore Diabetes & Endocrine Assoc., New Hyde Park
Endocrine Associates of Long Island, PC, Smithtown
Middle Country Endocrinology, P.C., Smithtown
Alan B. Schorr, DO FACE, Langhorne
MODEL Clinical Research, Baltimore
PMG Research of Winston-Salem, Winston-Salem
Physicians East, PA, Greenville
Diabetes & Endocrinology Consultants, Morehead City
Down East Medical Associates, Morehead City
Endocrine Research Solutions, Inc., Roswell
Atlanta Diabetes Associates, Atlanta
Albert Johary M.D., P.C., Dunwoody
MEDSOL Clinical Research Center, Port Charlotte
University Diabetes & Endocrine Consultants, Chattanooga
PMG Research of Bristol, Bristol
PMG Research of Knoxville, Knoxville
Grunberger Diabetes Institute, Bloomfield Hills
MidAmerica Diabetes Associates, Wichita
Regional Endocrinology Associates, PC, Santa Fe
San Diego Coastal Endocrinology Group, Chula Vista
Nancy J. Bohannon Med. Corp, San Francisco
Western Connecticut Health Network, Inc., Danbury
North Jersey Endocrine Consultants, LLCAND, Denville
Parsippany Endocrine, LLC, Parsippany
Collaborators (1)
Integrated Medical Development
INDUSTRY
Valeritas, Inc.
INDUSTRY